Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zoetis set to acquire Abaxis
The veterinary diagnostics category is estimated to be worth more than $3 billion.
Merger will enhance Zoetis’ presence in veterinary diagnostics

Leading animal health company Zoetis has announced plans to merge with Abaxis, a leading global provider of veterinary diagnostic instruments.

In a joint press release, the companies said the move would enhance Zoetis’ presence in veterinary diagnostics.

Zoetis chief executive officer Juan Ramon Alaix said: “Together we can bring more veterinarian customers a broader range of products that fit into our comprehensive solutions and innovations, from prediction and early detection of disease in animals to prevention and treatment.”

Abaxis chairman and chief executive officer Clint Severson added: “We see a prime opportunity to grow our business as part of Zoetis. We recently invested in expanding operations in Europe, Latin America, and the Asia Pacific Region, with 20 per cent of revenue in fiscal year 2018 coming from our international operations.

“Zoetis has the global presence and direct veterinary customer relationships to deliver greater value to more customers around the world and accelerate the growth of our international operations.”

The veterinary diagnostics category is estimated to be worth more than $3 billion, with a compound annual growth of 10 per cent over the past three years.

Zoetis expects the diagnostics category to continue faster than the animal health industry, with growth driven by rising medicalisation rates, increasing standards of veterinary care and the convenience of in-clinic testing.

Zoetis expects to complete the acquisition by the end of 2018 and says that it intends to fund the purchase through a combination of existing cash and new debt.

Become a member or log in to add this story to your CPD history

New single-dose RHD-2 vaccine launched

News Story 1
 The first monovalent vaccine to be registered in Europe for the prevention of rabbit hemorrhagic disease type 2 (RHD-2) has been launched by animal health firm HIPRA.

ERAVAC is a single-dose injectable emulsion that can be administered without the need for reconstitution beforehand. The new presentation contains 10 vials with individual doses that can be given to companion rabbits from 30 days of age. 

Click here for more...
News Shorts
New canine and feline dentistry manual announced

A new canine and feline dentistry and oral surgery manual has been published by the BSAVA. Announcing the news on its website, the BSAVA said this latest edition contains new step-by-step operative techniques, together with full-colour illustrations and photographs.

‘This is a timely publication; veterinary dentistry is a field that continues to grow in importance for the general veterinary practitioner,’ the BSAVA said. ‘The manual has been fully revised and updated to include the most relevant, evidence-based techniques.’

The BSAVA Manual of Canine and Feline Dentistry and Oral Surgery, 4th edition is available to purchase from www.bsava.com/shop